期刊文献+

血清C肽与2型糖尿病患者血糖控制及并发症的关系分析 被引量:31

Relationships of serum C-peptide with blood glucose control and diabetic complications
原文传递
导出
摘要 回顾性分析717例2型糖尿病患者临床资料,根据患者血清C肽水平将其分为正常C肽组(〉1.1 ng/ml)与低C肽组(〈1.1 ng/ml)。结果显示,正常C肽组HbA1C、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)以及总胆固醇(TC)水平显著低于低C肽组(P〈0.05或P〈0.01);正常C肽组糖尿病视网膜病变发生率显著低于低C肽组(P〈0.05);冠心病的发生率显著高于低C肽组(P〈0.01);Pearson相关性分析显示血清C肽与HbA1C、LDL-C、TC、HDL-C呈负相关(P〈0.05),与冠心病发病呈正相关(P〈0.01)。Logistic回归分析显示C肽是冠心病的独立影响因素。 The clinical data of 717 patients with type 2 diabetes were retrospectively analyzed. These patients were divided into normal C-peptide group(〉1.1 ng/ml) and low C-peptide group(〈1.1 ng/ml) based on C-peptide levels. The results showed that HbA1C, high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C), and total cholesterol (TC) levels in normal C-peptide group were lower than those in low C-peptide group (P〈0.05 or P〈0.01). The incidence of diabetic retinopathy (P〈0.05) was lower and that of coronary arterial disease (P〈0.01) was higher in normal C-peptide group as compared with low C-peptide group. Serum C-peptide level was negatively correlated with HbA1C, HDL-C, LDL-C, and TC (P〈0.05), and positively correlated with coronary arterial disease. C-peptide was the independent influencing factor of coronary heart disease shown by the logistic regression.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2013年第5期380-382,共3页 Chinese Journal of Endocrinology and Metabolism
基金 江苏省自然科学基金(BK2010121)
关键词 血清C肽 糖尿病 2型 血糖控制 糖尿病并发症 Serum C-peptide Diabetes mellitus, type 2 Blood glucose control Diabetic complications
  • 相关文献

参考文献9

  • 1Paterson AD, Rutledge BN, Cleary PA, et al. The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes : the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Diabetes Care, 2007,30:2107-2112.
  • 2Panero F, Novelli G, Zucco C, et al. Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients. Diabetes Care, 2009,32:301-305.
  • 3Wahren J, J6rnvall H. C-peptide makes a comeback. Diabetes Metab Res Rev, 2003,19 : 345-347.
  • 4Bo S, Gentile L, Castiglione A, et al. C-peptide and the risk for incident complications and mortality in type 2 diabetic patients : a retrospectivecohort study after a 14-year follow-up. Eur J Endocrinol, 2012,167: 173-180.
  • 5Kim BY, Jung CH, Mok JO, et al. Association between serum C- peptide levels and chronic microvascular complications in Korean type 2 diabetic patients. Acta diabetol, 2012,49:9-15.
  • 6Ekberg K, Brismar T, Johansson BL, et al. C-Peptide replacement therapy and sensory nerve function in type I diabetic neuropathy. Diabetes Care, 2007,30:71-76.
  • 7Samnegard B, Jacobson SH, Jaremko GH, et al. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int, 2001,60 : 1258-1265.
  • 8常家巍,高永峰.2型糖尿病视网膜病变血清C肽测定及临床意义[J].中国实用眼科杂志,2011,29(4):337-340. 被引量:9
  • 9Walcher D, Aleksic M, Jerg V, et al. C-Peptide induces chemotaxis of human cd4-positive cells involvement of pertussis toxin-sensitive G- proteins and phosphdnositide 3-kinase. Diabetes, 2004, 53 : 1664- 1670.

二级参考文献15

  • 1Bo S,Cavallo-Perin P,Gentile L,et al.Relationship of residual beta-cell function,metabolic control and chronic complications in type 2diabetes mellitns[J].Acta Diabetol,2000,37(3):126-129.
  • 2Subhan SS,Bhuiyan ZI,Akter K,et al.Relation between insulin secretory capacity and microangiopathy in young diabetes patients in Bangladesh[J].Myrnensingh Med J,2007,16(1):1-6.
  • 3Johansson BL,Kernell A,Wahren J.Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1[J].J Clin Endocrinol Metab,1993,77 (4):976-981.
  • 4Ido Y,Vindigni A,Chang K,et al.Prevention of vascular and neural dysfunction in diabetic rats by C-peptide[J].Science,1997,277(5325):563-566.
  • 5Ekberg K,Juntti-Berggren L,Norrby A,et al.C-peptide improves sensory nerve function in type 1 diabetes and neuropathy[J].Diabetologia,2005,48(suppl 1):81.
  • 6Thompson DM,Begg IS,Harris C,et al.Reduced progression of diabetic retinopathy after islet cell transplantation compared with intensive medical therapy[J].Transplantation,2008,85(10):1400-1405.
  • 7Venturini M,Fiorina P,Maffi P,et al.Early increase of retinal arterial and venous blood flow velocities at color doppler imaging in brittle type 1 diabetes after islet transplant alone[J].Transplantation,2006,81:1274-1277.
  • 8Klein R,Klein BE,Moss SE.The Wisconsin Epidemiologic Study of Diabetic Retinopathy.XVI.The relationship of C-peptide to the incidence and progression of diabetic retinopathy[J].Diabetes,1995,44:796-801.
  • 9Nordwall M,Arnqvist HJ,Bojestjg M,et al.Good glycemic control remains crucial in prevention of late diabetic complications-the Linkoping Diabetes Complications Study[J].Pediatric Diabetes,2009,10(3):168-176.
  • 10Stratton IM,Kohner EM,Aldington SJ,et al.UKPDS 50:risk factors for incidence and progression of retinopathy in type Ⅱ diabetes over 6 years from diagnosis[J].Diabetologia,2001,44:156-163.

共引文献8

同被引文献204

引证文献31

二级引证文献212

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部